Antioxidant therapy for chronic hepatitis C after failure of interferon: Results of phase II randomized, double-blind placebo controlled clinical trial

Figure 1 Effect of antioxidant treatment on ALT (A) and AST (B) serum levels in part I with treatment group in solid lines and placebo in dashed lines.

Figure 2 Proportions of patients with improvement in ALT (A) and AST (B).

Figure 3 Effect of antioxidant treatment on ALT (A) and AST (B) serum levels in part II with treatment group in solid lines and placebo in dashed lines.

Figure 4 Effect of antioxidant therapy on viral RNA serum levels in part I (A) and part II (B). .